Polymer Capital Management (Us) LLC Harmony Biosciences Holdings, Inc. Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 6,602 shares of HRMY stock, worth $225,986. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,602Holding current value
$225,986% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
277Shares Held
44.7MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$227 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$200 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$161 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$54.1 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$44.1 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.03B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...